WebApr 10, 2024 · According to analysts' consensus price target of $42.69, Q2 has a forecasted upside of 83.9% from its current price of $23.22. Amount of Analyst Coverage Q2 has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. See Top Rated MarketRank™ Stocks Here About Q2 (NYSE:QTWO) Stock
Q2 Holdings: Great Story, Great Opportunity -- but No Profits
WebMar 31, 2024 · Q2 Holdings Inc. (QTWO) full year performance was -63.07%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Q2 Holdings Inc. shares are logging -63.30% during the 52-week period from high price, and 25.86% higher than the ... WebQ2 Holdings (QTWO) Insiders Make Significant Share Sales Extending the Trend of Last Quarter Mar 15, 2024 MT Newswires Insider Trends: Q2 Holdings Insider Reports Option Conversion in Face of 90-Day Selling Trend poag eval ophthalmology
Q2 Holdings, Inc. (QTWO) - Yahoo Finance
WebThese two cultivators may the next targets. Against this backdrop, cannabis investors are probably curious about which companies are likely to be the next acquisition targets. Fortunately, the ... WebQTWO Q2 Holdings Inc. Financial Statements - WSJ Q2 Holdings Inc. QTWO (U.S.: NYSE) View All companies AT CLOSE 4:00 PM EST 02/13/23 $ USD AFTER HOURS 5:56 PM EST 02/13/23 34.27 0.51... WebMar 15, 2024 · AUSTIN, Texas-- (BUSINESS WIRE)--Q2 Holdings, Inc. (NYSE:QTWO), a leading provider of digital transformation solutions for banking and lending, today announced it once again received the 2024 Top Wor... 1 month ago - Business Wire Q2 Announces Fourth Capital as Its First Bank Partner to Offer Rocket Mortgage's Digital … poag disease